Related Experiment Videos

Improved cholesterol management in coronary heart disease patients enrolled in an HMO

A T Khoury1, G J Wan, O N Niedermaier

  • 1Kaiser Permanente of Ohio, USA. allan.khoury@kp.org

Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality
|March 22, 2001
PubMed

Insights

Physician reminders effectively improved cholesterol management for coronary heart disease (CHD) patients by increasing low-density lipoprotein cholesterol (LDL-C) measurement and goal achievement. A specialized clinic was underutilized.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Health Services Research

Background:

  • Coronary heart disease (CHD) management requires optimal cholesterol control.
  • Achieving low-density lipoprotein cholesterol (LDL-C) goals is crucial for CHD patients.
  • Current LDL-C measurement and goal attainment rates may be suboptimal.

Purpose of the Study:

  • To evaluate the impact of physician reminders on LDL-C measurement.
  • To assess the effect of reminders on achieving LDL-C goals (< or = 100 mg/dL) in CHD patients.
  • To explore the utilization of an additional cholesterol-lowering clinic.

Main Methods:

  • Retrospective analysis of patient data before and after reminder implementation.
  • Tracking of LDL-C measurement documentation rates.
  • Monitoring of LDL-C goal achievement percentages.
  • Assessing the usage of a supplementary cholesterol-lowering clinic.

Main Results:

  • The proportion of CHD patients with documented LDL-C decreased from 30% to 18% after reminders.
  • The percentage of CHD patients achieving their LDL-C goal increased from 10% to 27%.
  • The cholesterol-lowering clinic was rarely utilized by physicians.

Conclusions:

  • Physician reminders are an effective strategy to enhance cholesterol management in CHD patients.
  • Reminders can significantly improve LDL-C measurement and goal attainment.
  • Barriers to the utilization of specialized cholesterol-lowering clinics may exist.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...